• Users Online: 150
  • Print this page
  • Email this page
This article has been cited by
1Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders
Charlene Y. C. Chau,Loraine L. W. Chow,Siddharth Sridhar,Kendrick C. Shih
Ophthalmology and Therapy.2021;10(2)201
[DOI]
2Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
Luca Spiro Santovito,Graziano Pinna
Inflammation Research.2021;70(9)931
[DOI]
3SARS-CoV-2 among the Potential Viral Triggers for Vogt-Konayagi-Harada Disease: First Case Report and Literature Review
Ana Santamaria,Julian Chang,Christian Savarain
Ocular Immunology and Inflammation.2021;70(9)1
[DOI]
4Evaluation of Pupillometric Parameters in Patients with COVID-19
Yücel Öztürk,Merve Beyza Yildiz,Rüveyde Bolaç
Ocular Immunology and Inflammation.2021;70(9)1
[DOI]
5Concurrent and Post COVID-19 Ophthalmological Implications
Tamer EE Wasfy,Mohamed A Eldesouky,Yasser Serag,Hazem A Elbedewy
Clinical Ophthalmology.2021;Volume 15(9)4467
[DOI]
6Pattern of ocular manifestations and the prevalence of severe acute respiratory syndrome coronavirus-2 in tears of hospitalized coronavirus disease 2019 patients
Gaurang Sehgal,Prempal Bal,Bhavkaran Bal,Riya Chopra
Taiwan Journal of Ophthalmology.2021;11(4)380
[DOI]